Prevalence of Hepatocellular Carcinoma in HIV Patients Co-infected or Triple Infected With Hepatitis B and Hepatitis C in a Community Hospital in South Bronx

• Published in: Curēus (Palo Alto, CA) CA), 2022-06, Vol.14 (6), p.e26089-e26089
• Main Authors: Mehershanhi, Shehriyar, Haider, Asim, Kandhi, Sameer, Sun, Haozhe, Patel, Harish
• Format: Article
• Language: English
• Subjects: Comorbidity; Gastroenterology; Hepatitis; Hepatitis B; Hepatitis C; HIV; HIV/AIDS; Human immunodeficiency virus; Interferon; Internal Medicine; Liver cancer; Viruses
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.26089

BackgroundHuman immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) share common modes of transmission; hence HBV and HCV infection are more prevalent among HIV patients. The co-infection with HIV/HBV, HIV/HCV, or HIV/HBV/HCV carries significant morbidity, with higher progression rates to end-stage liver disease or hepatocellular carcinoma (HCC).MethodsWe conducted a retrospective study among HIV adult patients co-infected with HBV or HCV and those with HCV, HIV, and HBV triple infection enrolled in the outpatient clinic of BronxCare Hospital between the years 2010 and 2021. Records were reviewed to obtain demographic data, including age and sex, hepatitis B surface antigen (HBsAg), anti-HCV antibodies, and CD4 T-lymphocyte count test results. Male and female patients ≥18 years with confirmed HIV by double enzyme-linked immunoassay (ELISA) and western blot, who underwent serology testing for both HBsAg and anti-HCV, were included in the study.ResultsIn this study, 11355 HIV patients were included, comprising 7020 (61.8%) males and 4335 (38.2%) females. A total of 410 (3.6%) were hepatitis B positive, 1432 (12.6%) were hepatitis C positive, and 127 (1.1%) were both hepatitis B and C positive. Fifty-two (0.5%) patients were diagnosed with HCC. The majority of the patient with HCC (50%, n =26) were hepatitis C serology positive (p